Across Europe there are considerable challenges in clearing the ‘fourth hurdle’, with healthcare technology assessment in a number of key markets facing change and uncertainty.
In this PME market access supplement we look at the direction of travel in France and Germany and there’s an introduction to the UK’s new-look Cancer Drugs Fund.
We also hear about the improvements in the Turkish market – currently the largest country in the MENAT bloc, but hoping for greater standing in Europe should its EU dreams be realised.market access
